Tech Company Financing Transactions
Cerulean Pharma Funding Round
Cerulean Pharma, operating out of Cambridge, scored $13 million from Bessemer Venture Partners, Lux Capital and Polaris Partners.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr.
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Overview
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Friedman
VP - Bus. Development
Christopher Guiffre
VP - Finance
Karen Roberts
VP - Manufacturing
Marc Wolfgang
VP - R & D
Scott Eliasof
Browse more venture capital transactions:
Prev: 12/31/2012: Ubiquity Global Services venture capital transaction
Next: 12/31/2012: 3-V Biosciences venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs